AAAAAA
Results: 1-25/38
Authors:
Malcolm, E
Arruda, E
Hayden, FG
Kaiser, L
Citation: E. Malcolm et al., Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages, J CLIN VIRO, 21(1), 2001, pp. 9-16
Authors:
Whitley, RJ
Hayden, FG
Reisinger, KS
Young, N
Dutkowski, R
Ipe, D
Mills, RG
Ward, P
Citation: Rj. Whitley et al., Oral oseltamivir treatment of influenza in children, PEDIAT INF, 20(2), 2001, pp. 127-133
Authors:
Schmidt, AC
Couch, RB
Galasso, GJ
Hayden, FG
Mills, J
Murphy, BR
Chanock, RM
Citation: Ac. Schmidt et al., Current research on respiratory viral infections: Third International Symposium, ANTIVIR RES, 50(3), 2001, pp. 157-196
Authors:
Zambon, M
Hayden, FG
Citation: M. Zambon et Fg. Hayden, Position statement: global neuraminidase inhibitor susceptibility network, ANTIVIR RES, 49(3), 2001, pp. 147-156
Authors:
Kaiser, L
Fritz, RS
Straus, SE
Gubareva, L
Hayden, FG
Citation: L. Kaiser et al., Symptom pathogenesis during acute influenza: Interleukin-6 and other cytokine responses, J MED VIROL, 64(3), 2001, pp. 262-268
Authors:
Gubareva, LV
Webster, RG
Hayden, FG
Citation: Lv. Gubareva et al., Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants, ANTIM AG CH, 45(12), 2001, pp. 3403-3408
Authors:
Hayden, FG
Elliot, MJ
Citation: Fg. Hayden et Mj. Elliot, Zanamivir to prevent influenza. Reply, N ENG J MED, 344(7), 2001, pp. 529-530
Authors:
Gubareva, LV
Kaiser, L
Matrosovich, MN
Soo-Hoo, Y
Hayden, FG
Citation: Lv. Gubareva et al., Selection of influenza virus mutants in experimentally infected volunteerstreated with oseltamivir, J INFEC DIS, 183(4), 2001, pp. 523-531
Authors:
Hayden, FG
Fullwiler, ST
Citation: Fg. Hayden et St. Fullwiler, Analysis of the financial assurance plan in the license application for a low-level radioactive waste disposal facility, J ECON ISS, 35(2), 2001, pp. 373-383
Authors:
Hayden, FG
Jennings, L
Robson, R
Schiff, G
Jackson, H
Rana, B
McClelland, G
Ipe, D
Roberts, N
Ward, P
Citation: Fg. Hayden et al., Oral oseltamivir in human experimental influenza B infection, ANTIVIR TH, 5(3), 2000, pp. 205-213
Authors:
Hayden, FG
Menegus, MA
Monto, AS
Newton, DW
Treanor, JJ
Citation: Fg. Hayden et al., The diagnosis and treatment of influenza: A managed care perspective, AM J M CARE, 6(5), 2000, pp. S244-S246
Authors:
Hayden, FG
Citation: Fg. Hayden, Advances in the prophylaxis and treatment of influenza illness, AM J M CARE, 6(5), 2000, pp. S247-S254
Authors:
Rotbart, HA
Hayden, FG
Citation: Ha. Rotbart et Fg. Hayden, Picornavirus infections - A primer for the practitioner, ARCH FAM M, 9(9), 2000, pp. 913-920
Authors:
Kaiser, L
Henry, D
Flack, NP
Keene, O
Hayden, FG
Citation: L. Kaiser et al., Short-term treatment with zanamivir to prevent influenza: Results of a placebo-controlled study, CLIN INF D, 30(3), 2000, pp. 587-589
Authors:
Hayden, FG
Citation: Fg. Hayden, Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention, VACCINE, 19, 2000, pp. S66-S70
Authors:
Kaiser, L
Crump, CE
Hayden, FG
Citation: L. Kaiser et al., In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses, ANTIVIR RES, 47(3), 2000, pp. 215-220
Authors:
Munoz, FM
Galasso, GJ
Gwaltney, JM
Hayden, FG
Murphy, B
Webster, R
Wright, P
Couch, RB
Citation: Fm. Munoz et al., Current research on influenza and other respiratory viruses: II International Symposium, ANTIVIR RES, 46(2), 2000, pp. 91-124
Authors:
Gubareva, LV
Kaiser, L
Hayden, FG
Citation: Lv. Gubareva et al., Influenza virus neuraminidase inhibitors, LANCET, 355(9206), 2000, pp. 827-835
Authors:
Treanor, JJ
Hayden, FG
Vrooman, PS
Barbarash, R
Bettis, R
Riff, D
Singh, S
Kinnersley, N
Ward, P
Mills, RG
Citation: Jj. Treanor et al., Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial, J AM MED A, 283(8), 2000, pp. 1016-1024
Authors:
Hayden, FG
Gubareva, LV
Monto, AS
Klein, TC
Elliott, MJ
Hammond, JM
Sharp, SJ
Ossi, MJ
Citation: Fg. Hayden et al., Inhaled zanamivir for the prevention of influenza in families., N ENG J MED, 343(18), 2000, pp. 1282-1289
Authors:
Belshe, RB
Gruber, WC
Mendelman, PM
Cho, I
Reisinger, K
Block, SL
Wittes, J
Iacuzio, D
Piedra, P
Treanor, J
King, J
Kotloff, K
Bernstein, DI
Hayden, FG
Zangwill, K
Yan, LH
Wolff, M
Citation: Rb. Belshe et al., Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine, J PEDIAT, 136(2), 2000, pp. 168-175
Authors:
Belshe, RB
Gruber, WC
Mendelman, PM
Mehta, HB
Mahmood, K
Reisinger, K
Treanor, J
Zangwill, Z
Hayden, FG
Bernstein, DI
Kotloff, K
King, J
Piedra, PA
Block, SL
Yan, LH
Wolff, M
Citation: Rb. Belshe et al., Correlates of immune protection induced by live, attenuated, cold-adapted,trivalent, intranasal influenza virus vaccine, J INFEC DIS, 181(3), 2000, pp. 1133-1137
Authors:
Kaiser, L
Keene, ON
Hammond, JMJ
Elliott, M
Hayden, FG
Citation: L. Kaiser et al., Impact of Zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults, ARCH IN MED, 160(21), 2000, pp. 3234-3240
Authors:
Kaiser, L
Briones, MS
Hayden, FG
Citation: L. Kaiser et al., Performance of virus isolation and Directigen (R) Flu A to detect influenza A virus in experimental human infection, J CLIN VIRO, 14(3), 1999, pp. 191-197
Authors:
Calfee, DP
Peng, AW
Hussey, EK
Lobo, M
Hayden, FG
Citation: Dp. Calfee et al., Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection, ANTIVIR TH, 4(3), 1999, pp. 143-149